Chemotherapy News and Research

Latest Chemotherapy News and Research

UGA researchers find new way to improve cancer-killing power of chemotherapy

UGA researchers find new way to improve cancer-killing power of chemotherapy

High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

Researchers identify potential new treatment for brain cancer by targeting genes linked to microcephaly

Researchers identify potential new treatment for brain cancer by targeting genes linked to microcephaly

Study shows only 44% of patients receive accepted, best treatment for cervical cancer

Study shows only 44% of patients receive accepted, best treatment for cervical cancer

Combination treatment can reduce tumor's resistance to chemotherapy in ovarian cancer

Combination treatment can reduce tumor's resistance to chemotherapy in ovarian cancer

NUS researchers identify molecular switch that makes breast cancer cells more aggressive

NUS researchers identify molecular switch that makes breast cancer cells more aggressive

Researchers identify protein linked to negative effects of senescence

Researchers identify protein linked to negative effects of senescence

Penn study reveals new sights into how some intestinal cells can withstand chemotherapy and radiation

Penn study reveals new sights into how some intestinal cells can withstand chemotherapy and radiation

Simple web-based program may help alleviate mild cognitive problems in cancer survivors

Simple web-based program may help alleviate mild cognitive problems in cancer survivors

Standardize 4 Safety initiative finalizes list of recommendations for adult IV continuous infusions

Standardize 4 Safety initiative finalizes list of recommendations for adult IV continuous infusions

Study estimates prevalence of self-reported immunosuppressed adults in the U.S.

Study estimates prevalence of self-reported immunosuppressed adults in the U.S.

Research findings may lead to new treatment option for ovarian cancer

Research findings may lead to new treatment option for ovarian cancer

Non-toxic Salmonella strain could be promising new treatment option for cancer

Non-toxic Salmonella strain could be promising new treatment option for cancer

New Penn Medicine study raises questions about NLR as biomarker for bladder cancer

New Penn Medicine study raises questions about NLR as biomarker for bladder cancer

Scientists find new way to see where certain cancer drugs accumulate in the body

Scientists find new way to see where certain cancer drugs accumulate in the body

Immunotherapy drug approved by FDA as first-line treatment for non-small cell lung cancer

Immunotherapy drug approved by FDA as first-line treatment for non-small cell lung cancer

Painful sex in women after cancer needs to be addressed, UC Davis researcher suggests

Painful sex in women after cancer needs to be addressed, UC Davis researcher suggests

Screening for prolactin receptor could help improve TNBC prognosis and treatment

Screening for prolactin receptor could help improve TNBC prognosis and treatment

Basal tumor cell marker could help physicians personalize care for patients with bladder cancer

Basal tumor cell marker could help physicians personalize care for patients with bladder cancer

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.